Cargando…
Prognostic Relevance of Pretherapeutic Gamma-Glutamyltransferase in Patients with Primary Metastatic Breast Cancer
BACKGROUND: Gamma-glutamyltransferase (GGT) is a known marker for apoptotic balance and cell detoxification. Recently, an association of baseline GGT levels and breast cancer incidence, tumor progression and chemotherapy resistance was shown. The purpose of this study was to evaluate the association...
Autores principales: | Staudigl, Christine, Concin, Nicole, Grimm, Christoph, Pfeiler, Georg, Nehoda, Regina, Singer, Christian F., Polterauer, Stephan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411095/ https://www.ncbi.nlm.nih.gov/pubmed/25915044 http://dx.doi.org/10.1371/journal.pone.0125317 |
Ejemplares similares
-
Gamma-glutamyltransferase as novel biomarker in patients with uterine leiomyosarcoma
por: Schwameis, Richard, et al.
Publicado: (2016) -
Prognostic impact of pretherapeutic gamma-glutamyltransferase on patients with nasopharyngeal carcinoma
por: Wen, Yue-Feng, et al.
Publicado: (2017) -
Pretherapeutic gamma-glutamyltransferase is an independent prognostic factor for patients with renal cell carcinoma
por: Hofbauer, S L, et al.
Publicado: (2014) -
Prognostic significance of gamma-glutamyltransferase in patients with endometrial cancer: a multi-centre trial
por: Seebacher, V, et al.
Publicado: (2012) -
Association of gamma-glutamyltransferase with severity of disease at diagnosis and prognosis of ovarian cancer
por: Grimm, C, et al.
Publicado: (2013)